Trials / Completed
CompletedNCT00945841
Safety and Immunogenicity, Inactivated Split Influenza Vaccine, Using the Strain Composition 2009/2010
A Phase III, Multicenter, Uncontrolled, Open-label Study to Evaluate Safety and Immunogenicity of a Preservative Free, Inactivated Split Influenza Vaccine, Using the Strain Composition 2009/2010 When Administered to Adult and Elderly Subjects
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 126 (actual)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This study is an annual trial for registration of inactivated split influenza vaccine with strain composition for season 2009/2010.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | inactivated split influenza vaccine | 1 dose of inactivated split influenza vaccine, using the strain composition 2009/2010 |
Timeline
- Start date
- 2009-06-01
- Primary completion
- 2009-06-01
- Completion
- 2009-06-01
- First posted
- 2009-07-24
- Last updated
- 2017-04-07
Locations
3 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT00945841. Inclusion in this directory is not an endorsement.